Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome
Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus
10.2147/DMSO.S447659 18
The project is supported by the Italian PNRR-MAD project (PNRR-MAD-2022-12375656)
Factors typically reviewed include injury type and severity, medical history, current medications, and rehabilitation status
Most adverse events were gastrointestinal, such as nausea, diarrhea, or constipation, and occurred in 79.6% of the combination arm versus 39.9% of placebo recipients
US$ 29.36
US$ 24.21
US$ 22.40
/assets/production/practices/438b59b4e27c5dc64b6d75ab18cf4e16804f233b/images/2831064.png)
US$ 21.30
